151 related articles for article (PubMed ID: 21777717)
41. Assessing decisional capacity for research participation in psychiatric patients and their relatives.
George DE; Dholakia S; Tharyan P
Indian J Med Ethics; 2018; 3(2):125-133. PubMed ID: 28918381
[TBL] [Abstract][Full Text] [Related]
42. A new brief instrument for assessing decisional capacity for clinical research.
Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
[TBL] [Abstract][Full Text] [Related]
43. Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent.
Glezer A; Stern TA; Mort EA; Atamian S; Abrams JL; Brendel RW
Psychosomatics; 2011; 52(6):521-9. PubMed ID: 22054621
[TBL] [Abstract][Full Text] [Related]
44. Key factors in children's competence to consent to clinical research.
Hein IM; Troost PW; Lindeboom R; Benninga MA; Zwaan CM; van Goudoever JB; Lindauer RJ
BMC Med Ethics; 2015 Oct; 16(1):74. PubMed ID: 26498961
[TBL] [Abstract][Full Text] [Related]
45. Clinical ethics issues in geriatric psychiatry.
Walaszek A
Psychiatr Clin North Am; 2009 Jun; 32(2):343-59. PubMed ID: 19486818
[TBL] [Abstract][Full Text] [Related]
46. [Mental competence and informed consent. Clinical practice and ethical analysis].
Vollmann J
Nervenarzt; 2000 Sep; 71(9):709-14. PubMed ID: 11042865
[TBL] [Abstract][Full Text] [Related]
47. Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease.
Moro V; Valbusa V; Corsi N; Bonazzi A; Condoleo MT; Broggio E; Gambina G
Neurol Sci; 2020 May; 41(5):1225-1231. PubMed ID: 31901122
[TBL] [Abstract][Full Text] [Related]
48. Capacity to provide informed consent for participation in schizophrenia and HIV research.
Moser DJ; Schultz SK; Arndt S; Benjamin ML; Fleming FW; Brems CS; Paulsen JS; Appelbaum PS; Andreasen NC
Am J Psychiatry; 2002 Jul; 159(7):1201-7. PubMed ID: 12091200
[TBL] [Abstract][Full Text] [Related]
49. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
Palmer BW; Dunn LB; Appelbaum PS; Mudaliar S; Thal L; Henry R; Golshan S; Jeste DV
Arch Gen Psychiatry; 2005 Jul; 62(7):726-33. PubMed ID: 15997013
[TBL] [Abstract][Full Text] [Related]
50. Decisional capacity for informed consent in schizophrenia research.
Carpenter WT; Gold JM; Lahti AC; Queern CA; Conley RR; Bartko JJ; Kovnick J; Appelbaum PS
Arch Gen Psychiatry; 2000 Jun; 57(6):533-8. PubMed ID: 10839330
[TBL] [Abstract][Full Text] [Related]
51. Advance consent for dementia research.
Sachs GA
Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):19-27. PubMed ID: 11657670
[TBL] [Abstract][Full Text] [Related]
52. Surrogate consent for dementia research: a national survey of older Americans.
Kim SY; Kim HM; Langa KM; Karlawish JH; Knopman DS; Appelbaum PS
Neurology; 2009 Jan; 72(2):149-55. PubMed ID: 19139366
[TBL] [Abstract][Full Text] [Related]
53. [Capacity to consent to treatment in dementia patients : Interdisciplinary perspectives].
Haberstroh J; Müller T
Z Gerontol Geriatr; 2017 Jun; 50(4):298-303. PubMed ID: 28534169
[TBL] [Abstract][Full Text] [Related]
54. What do people at risk for Alzheimer disease think about surrogate consent for research?
Schenk DB; Gilman S
Neurology; 2006 Jun; 66(11):1785-6. PubMed ID: 16769971
[No Abstract] [Full Text] [Related]
55. The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia.
Rikkert MG; Lauque S; Frölich L; Vellas B; Dekkers W
Eur J Neurol; 2005 Mar; 12(3):212-7. PubMed ID: 15693811
[TBL] [Abstract][Full Text] [Related]
56. Decision-making capacity, memory and informed consent, and judgment at the boundaries of the self.
Haque OS; Bursztajn H
J Clin Ethics; 2007; 18(3):256-61. PubMed ID: 18051944
[No Abstract] [Full Text] [Related]
57. Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
Kim SY; Appelbaum PS; Swan J; Stroup TS; McEvoy JP; Goff DC; Jeste DV; Lamberti JS; Leibovici A; Caine ED
Br J Psychiatry; 2007 Jul; 191():38-43. PubMed ID: 17602123
[TBL] [Abstract][Full Text] [Related]
58. Field reliability of competence to stand trial opinions: How often do evaluators agree, and what do judges decide when evaluators disagree?
Gowensmith WN; Murrie DC; Boccaccini MT
Law Hum Behav; 2012 Apr; 36(2):130-9. PubMed ID: 22471417
[TBL] [Abstract][Full Text] [Related]
59. The preferences of potential stakeholders in psychiatric genomic research regarding consent procedures and information delivery.
Sundby A; Boolsen MW; Burgdorf KS; Ullum H; Hansen TF; Middleton A; Mors O
Eur Psychiatry; 2019 Jan; 55():29-35. PubMed ID: 30384109
[TBL] [Abstract][Full Text] [Related]
60. Living wills and substituted judgments: a critical analysis.
Welie JV
Med Health Care Philos; 2001; 4(2):169-83. PubMed ID: 11547503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
